Best Medical Oncologists for Lung Cancer in Hyderabad, India
This page lists 14 lung cancer doctors in Hyderabad, India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.
Quick answer
This page lists 14 lung cancer doctors in Hyderabad, India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.
About Lung Cancer doctors in Hyderabad, India
This directory is based on doctors currently listed in GAF Healthcare's registry. Clinical suitability varies by patient; a doctor should review your history and investigations before any treatment decision.
About the Condition
What is Lung Cancer?
Lung cancer occurs when abnormal cells in the lung tissue grow in an uncontrolled way, forming tumours that can interfere with breathing and spread to other parts of the body if not detected and treated early. It is one of the most common cancers worldwide and a leading cause of cancer-related death, making timely diagnosis critically important. Risk factors include a history of smoking or passive smoke exposure, prolonged contact with asbestos, radon gas, or industrial chemicals, as well as a personal or family history of lung disease or prior cancer. A thorough assessment — including imaging, biopsy, and staging — is essential before any treatment plan can be recommended.
Individual assessmentEvery case is different
Complete evaluationUnderstand the condition first
Specialist reviewChoose the right approach
Medical assessment helps clarify severity and identify appropriate options.
Treatment options for Lung Cancer
Care may include lifestyle changes, medical treatment, specialist review or a procedure, depending on the diagnosis, associated conditions and individual goals. The options below are associated with this condition in the GAF Healthcare directory.
Stereotactic Body Radiation Therapy (SBRT) is a highly precise, non-invasive radiation technique that delivers very high doses of focused radiation to small, well-defined tumors in the lung, liver, or pancreas over just a few sessions.
Why it may be consideredIt uses advanced imaging and immobilization to spare surrounding healthy tissue while achieving tumor control comparable to surgery in select cases. SBRT is commonly used for early-stage or inoperable tumors, oligometastatic disease, or as a boost after other therapies.
Intensity-Modulated Radiation Therapy (IMRT) is an advanced form of external beam radiotherapy that uses computer-controlled linear accelerators to deliver precisely shaped radiation doses conforming to the exact 3D shape of a tumor.
Why it may be consideredBy modulating beam intensity from multiple angles, IMRT maximizes tumor cell destruction while sparing surrounding healthy tissue, making it especially valuable for lung, prostate, and head and neck cancers located near critical structures. It is typically delivered as a course of daily outpatient sessions over several weeks.
Chemotherapy is a systemic cancer treatment that uses potent drugs to destroy or slow the growth of cancer cells, either as a standalone treatment or combined with surgery and radiation therapy.
Why it may be consideredIt is typically administered in cycles over several weeks to months, tailored to the cancer type, stage, and patient's overall health. GAF Healthcare connects international patients with leading Indian oncology centers offering world-class chemotherapy protocols at a fraction of Western costs.
Immunotherapy uses drugs that help the patient's own immune system recognize and destroy cancer cells, and is used across many cancers including breast, lung, colorectal, gastric/esophageal, liver/pancreatic, ovarian/gynaecological, head & neck cancers, leukemia, lymphoma, and multiple myeloma.
Why it may be consideredIt is given as an infusion in cycles, either alone or combined with chemotherapy/targeted therapy, and India offers globally approved immunotherapy drugs and advanced options like CAR-T cell therapy at a fraction of Western costs. Treatment plans are individualized based on tumor type, biomarker status (e.g., PD-L1, MSI), and stage of disease.
Targeted therapy uses drugs designed to specifically identify and attack cancer cells based on genetic mutations, proteins, or receptors, while sparing normal healthy cells.
Why it may be consideredIt is used across breast, lung, colorectal, gastric, liver, pancreatic, prostate, ovarian, head & neck cancers, leukemia, lymphoma, and multiple myeloma, often guided by biomarker or genomic testing. India offers internationally accredited cancer centres with access to the latest targeted agents at a fraction of Western costs.
MBBS, MD (General Medicine), DM Hematology, DM Medical Oncology, American Board Certified in Internal Medicine, American Board Certified in Hematology, American Board Certified in Medical Oncology
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Yashoda Hospitals, Secunderabad Hyderabad, India26+ Years experience
Why consider this doctor?
26+ years of experience in Medical Oncologist
Senior Consultant, Medical Oncology, Yashoda Hospitals, Secunderabad, Hyderabad, India — Present
Consultant Hematologist and Medical Oncologist, various leading hospitals in Hyderabad and USA — 26+ years
Expertise & Procedures
Systemic Chemotherapy Administration
Targeted Molecular Therapy
Cancer Immunotherapy (CAR-T, Checkpoint Inhibitors)
MBBS, American Board Certification in Internal Medicine, American Board Certification in Hematology, American Board Certification in Medical Oncology, ECFMG Certification
Clinical Director, HOD & Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Yashoda Hospital Hyderabad, India23+ Years experience
Why consider this doctor?
23+ years of experience in Medical Oncologist
Clinical Director, HOD, and Senior Consultant in Medical Oncology — Yashoda Hospital, Hyderabad, India (Present)
Consultant Medical Oncologist — Care Hospitals, Hyderabad, India
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
Medical OncologyCardiac SurgeryCardiologySpine Surgery
Many international patients consider India for lung cancer treatment for several reasons, including:
More affordable estimates
Competitive indicative costs compared with many other countries, for similar clinical standards.
Internationally accredited hospitals
Hospitals experienced in treating international patients.
Experienced specialists
Doctors who regularly manage similar cases.
Care coordination support
A team to help with planning, medical translation and follow-up.
How this directory is built
Doctors are matched using the specialty, location, condition (Lung Cancer) recorded in their profiles. Inclusion is not an endorsement and does not guarantee a treatment outcome.
Need help with the next step?
Share your needs with our care coordination team for information about doctors and hospitals.
Common questions
FAQs about Lung Cancer in Hyderabad, India
What is Lung Cancer?
Lung cancer is a malignant condition in which cells in one or both lungs multiply abnormally, most commonly arising in the cells lining the airways (non-small cell lung cancer) or in neuroendocrine cells of the lung (small cell lung cancer). The distinction between these types, along with the tumour's stage and molecular profile, directly shapes the treatment approach.
What are the symptoms and health risks of Lung Cancer?
Common symptoms include a persistent or worsening cough, coughing up blood, unexplained shortness of breath, chest pain, hoarseness, unintentional weight loss, and recurrent chest infections. As the disease progresses or spreads, symptoms such as bone pain, headache, or swelling in the face and neck may also appear. It is important to note that these symptoms overlap with many other conditions, and their presence alone is not sufficient to establish a diagnosis.
How is Lung Cancer diagnosed?
Diagnosis typically begins with a detailed clinical history and physical examination, followed by chest X-ray or CT scan to identify suspicious lesions. A tissue biopsy — obtained bronchoscopically, via CT-guided needle, or surgically — is required to confirm the cancer type and, increasingly, to test for specific genetic mutations (such as EGFR, ALK, or PD-L1 expression) that guide targeted therapy decisions. Staging, usually described using the TNM system (Stage I through IV for non-small cell, and limited versus extensive for small cell), along with PET scan and sometimes brain MRI, determines how far the cancer has spread and which treatment pathways are appropriate.
How is Lung Cancer treated?
Treatment depends heavily on the cancer type, stage, molecular markers, and the patient's overall lung function and health status. Early-stage non-small cell lung cancer may be treated with surgery, stereotactic body radiation therapy (SBRT), or a combination of chemotherapy and radiation; advanced stages may involve systemic therapies such as chemotherapy, targeted agents, or immunotherapy, often combined with radiation therapy such as intensity-modulated radiation therapy (IMRT). Small cell lung cancer is generally managed with chemotherapy and radiation, and all decisions about sequencing and combining treatments are made by a multidisciplinary team following individual assessment.
Can Lung Cancer be treated without surgery?
Non-surgical pathways are well established and clinically significant for lung cancer. Stereotactic body radiation therapy (SBRT) is a recognised standard for early-stage tumours in patients who are not surgical candidates or who prefer to avoid surgery. For locally advanced or metastatic disease, chemotherapy, immunotherapy, targeted molecular therapies, and radiation therapy (including IMRT) form the backbone of treatment — meaning many patients receive effective care without any surgical procedure.
When is Stereotactic Body Radiation Therapy (SBRT) considered for Lung Cancer?
Stereotactic Body Radiation Therapy (SBRT) may be considered when conservative or medical options have not achieved enough improvement, or when the severity of the condition warrants it. The decision depends on clinical assessment, expected benefits and individual risks.
Which doctor treats Lung Cancer?
Lung cancer is typically evaluated and managed by a multidisciplinary team that may include a thoracic oncologist or medical oncologist (who oversees systemic therapies), a radiation oncologist (who plans and delivers SBRT or IMRT), a thoracic surgeon (for surgical cases), and a pulmonologist involved in initial diagnosis. A dedicated lung cancer tumour board — where specialists review each case collectively — is considered best practice at experienced centres.
How do I choose a doctor for Lung Cancer?
When comparing providers, look for centres with a dedicated thoracic or lung cancer programme, access to molecular tumour profiling, and an active multidisciplinary tumour board, as these factors are associated with more personalised and coordinated care. It is also worth asking about the radiation oncology team's specific experience with SBRT and IMRT for lung tumours, the technology available (such as image-guided or motion-management systems), and what structured follow-up and supportive care are offered after treatment.
What documents do international patients need to share for a medical evaluation?
Share a medical summary, investigation and imaging or biopsy reports where relevant, a current medication list, previous diagnoses and related treatment records. Provide clear copies with translation where needed.
How does GAF Healthcare help international patients plan treatment in India?
Our care coordination team helps review initial medical information, connect you with suitable doctors and hospitals, explain next steps and indicative estimates, and organise a treatment plan before travel.
